$15.02
-0.08[-0.53%]
At close: Apr 23
$15.02
0[0.00%]
After Hours: 4:36PM EDT
Catalyst Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Catalyst Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/08/2024 | PM | CPRX | Q1 | $0.41 | $0.24 | — | — | $85.37M | $99.52M | — | — | Get Alert |
02/28/2024 | PM | CPRX | Q4 | $0.31 | $0.26 | $0.53 | 103.85% | $60.76M | $106.12M | $110.57M | — | Get Alert |
11/08/2023 | PM | CPRX | Q3 | $0.26 | $0.44 | $0.49 | 11.36% | $57.24M | $100.38M | $102.69M | 2.30% | Get Alert |
08/09/2023 | PM | CPRX | Q2 | $0.28 | $0.42 | $0.53 | 26.19% | $53.11M | $92.73M | $99.58M | 7.39% | Get Alert |
05/10/2023 | PM | CPRX | Q1 | $0.12 | $0.32 | $0.41 | 28.12% | $43.09M | $81.62M | $85.37M | 4.59% | Get Alert |
03/15/2023 | PM | CPRX | Q4 | $0.09 | $0.21 | $0.31 | 47.62% | $38.31M | $58.09M | $60.76M | 4.59% | Get Alert |
11/09/2022 | PM | CPRX | Q3 | $0.10 | $0.19 | $0.26 | 36.84% | $35.95M | $53.62M | $57.24M | 6.76% | Get Alert |
08/09/2022 | PM | CPRX | Q2 | $0.11 | $0.17 | $0.28 | 64.71% | $36.37M | $49.21M | $53.11M | 7.93% | Get Alert |
05/10/2022 | PM | CPRX | Q1 | $0.07 | $0.14 | $0.12 | -14.29% | $30.20M | $42.75M | $43.09M | 0.79% | Get Alert |
03/16/2022 | PM | CPRX | Q4 | $0.11 | $0.12 | $0.09 | -25.00% | $31.02M | $38.19M | $38.31M | 0.31% | Get Alert |
11/09/2021 | PM | CPRX | Q3 | $0.13 | $0.10 | $0.10 | 0.00% | $29.32M | $34.59M | $35.95M | 3.94% | Get Alert |
08/09/2021 | PM | CPRX | Q2 | $0.09 | $0.09 | $0.11 | 22.22% | $29.61M | $31.51M | $36.37M | 15.41% | Get Alert |
05/10/2021 | PM | CPRX | Q1 | $0.10 | $0.09 | $0.07 | -22.22% | $29.14M | $32.10M | $30.20M | -5.90% | Get Alert |
03/15/2021 | PM | CPRX | Q4 | $0.07 | $0.09 | $0.11 | 22.22% | $30.12M | $30.35M | $31.02M | 2.19% | Get Alert |
11/09/2020 | PM | CPRX | Q3 | $0.13 | $0.10 | $0.13 | 30.00% | $30.90M | $31.49M | $29.32M | -6.90% | Get Alert |
08/10/2020 | PM | CPRX | Q2 | $0.10 | $0.08 | $0.09 | 12.50% | $28.84M | $29.48M | $29.61M | 0.42% | Get Alert |
05/11/2020 | PM | CPRX | Q1 | -$0.01 | $0.09 | $0.10 | 11.11% | $12.45M | $31.46M | $29.14M | -7.39% | Get Alert |
03/16/2020 | PM | CPRX | Q4 | -$0.14 | $0.10 | $0.07 | -30.00% | $500.00K | $29.40M | $30.12M | 2.46% | Get Alert |
11/12/2019 | PM | CPRX | Q3 | -$0.08 | $0.11 | $0.13 | 18.18% | $0.00 | $33.18M | $30.90M | -6.88% | Get Alert |
Catalyst Pharmaceuticals (CPRX) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $0.53, which beat the estimate of $0.26.
The Actual Revenue was $110.6M, which beat the estimate of $106.1M.
Browse earnings estimates, EPS, and revenue on all stocks.